Prostate cancer is the most frequent malignant neoplasm in men and the second most common cancer death among American men. Screening for prostate cancer should include testing for prostate specific antigen (PSA). Digital rectal exam (DRE) may also be used as a complementary baseline test.
Refer to ARUP Laboratories’ test offerings below.
ARUP Laboratory Tests
Method
Quantitative Chemiluminescent Immunoassay (CLIA)
Method
Quantitative Electrochemiluminescent Immunoassay
Method
Quantitative Electrochemiluminescent Immunoassay
Method
Electrochemiluminescent Immunoassay (ECLIA)